US5569608A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Quantitative detection of analytes on immunochromatographic strips
Assignee: Siemens Healthcare Diagnostics Inc
•
Filing: 1995-01-30
•
Granted: 1996-10-29
•
Expires: 2015-01-30
Abstract
Abstract A method for determining the concentration of analyte in a test fluid by immunochromatography techniques which involves quantitatively determining the signals from captured analyte/labeled binding partner complex by an instrument, e.g. reflectance spectrometer. In a preferred embodiment, a reflectance reading is determined for the captured complex and uncomplexed labeled binding partner which is captured in a separate zone of the immunochromatographic strip and the ratio of these reflectances is used to provide additional quantitation to the assay method.
Inventors
- 👤 Ronald G. Sommer
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-31 03:07
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/543; G01N33/54366; G01N33/54386; G01N33/54387; G01N33/54388; G01N30/00; G01N30/90; Y; Y10; Y10S; Y10S435/00; Y10S435/805; Y10S435/81; Y10S435/97; Y10S436/00; Y10S436/807; Y10S436/81
Claims Analysis
Total Claims: 18
Claim 1
Independent Claim
275 words
A method for determining the concentration of one or more analyte in a fluid test sample which comprises: a) providing a test strip comprising a matrix through which the fluid test sample can flow by capillarity wherein a first region of the strip contains mobile specific binding partner for the analyte which bears a detectable label and can react with the analyte to form an analyte/labeled binding partner complex and at least one second region which contains immobilized analyte or analog thereof, b) developing the strip by applying the fluid test sample suspected of containing the analyte thereto thereby allowing the same contact the mobile, labeled specific binding partner for the analyte whereby analyte present in the fluid test sample binds to the labeled specific binding partner to form the complex leaving excess, unreacted labeled binding partner free to further react whereby the fluid test sample carries the analyte/labeled binding partner complex and unreacted labeled binding partner along the strip by capillarity to the second region containing the immobilized analyte or analog thereof in which region unreacted labeled binding partner is bound to the inmlobilized analyte in inverse relationship to the concentration of analyte in the fluid test sample, c) reading the developed strip on an instrument having a detector capable of measuring the signal from the detectable label to determine the concentration of the labeled binding partner in the second region, and d) determining the concentration of analyte in the fluid test sample by comparing the signal from the detectable label measured in step c) with the measurements of the signal made in the same manner using fluid samples containing known concentrations of analyte.
Claim 2
Independent Claim
275 words
A method for determining the concentration of one or more analyte in a fluid test sample which comprises: a) providing a test strip comprising a matrix through which the fluid test sample can flow by capillarity wherein a first region of the strip contains mobile specific binding partner for the analyte which bears a detectable label and can react with the analyte to form an analyte/labeled binding partner complex and at least one second region which contains immobilized analyte or analog thereof, b) developing the strip by applying the fluid test sample suspected of containing the analyte thereto thereby allowing the same contact the mobile, labeled specific binding partner for the analyte whereby analyte present in the fluid test sample binds to the labeled specific binding partner to form the complex leaving excess, unreacted labeled binding partner free to further react whereby the fluid test sample carries the analyte/labeled binding partner complex and unreacted labeled binding partner along the strip by capillarity to the second region containing the immobilized analyte or analog thereof in which region unreacted labeled binding partner is bound to the inmlobilized analyte in inverse relationship to the concentration of analyte in the fluid test sample, c) reading the developed strip on an instrument having a detector capable of measuring the signal from the detectable label to determine the concentration of the labeled binding partner in the second region, and d) determining the concentration of analyte in the fluid test sample by comparing the signal from the detectable label measured in step c) with the measurements of the signal made in the same manner using fluid samples containing known concentrations of analyte.
Claim 3
Dependent Claim
70 words
The method of claim 1 wherein there is a third region of the strip which contains means for immobilizing the complex formed between the analyte and the labeled binding partner and measuring the signal from the detectable label immobilized in this third region and wherein the ratio of the signal from the labeled binding partner immobilized in the second region and the immobilized complex in the third region is determined.
Claim 4
Dependent Claim
37 words
The method of claim 1 wherein the instrument contains means for moving the strip or the detector relative to each other to give accurate quantitation for regions which may not have been precisely located on the instrument.
Claim 5
Dependent Claim
50 words
The method of claim 1 wherein there are two or more mobile labeled binding partners on the strip in the same or different first regions and two or more second regions containing immobilized analytes or analogs thereof, so that two or more analytes can be determined in a single test.
Claim 6
Dependent Claim
12 words
The method of claim 1 wherein the instrument is a reflectance spectrometer.
Claim 7
Dependent Claim
24 words
The method of claim 1 wherein the matrix is comprised of a material which is capable of non-bibulous lateral flow or a bibulous material.
Claim 8
Dependent Claim
12 words
The method of claim 1 wherein the analyte is human serum albumin.
Claim 9
Dependent Claim
13 words
The method of claim 1 wherein the detectable label is a colored species.
Claim 10
Dependent Claim
13 words
The method of claim 8 wherein the colored species is a gold sol.
Claim 11
Dependent Claim
13 words
The method of claim 1 wherein the labeled binding partner is an antibody.
Claim 12
Independent Claim
391 words
A method for quantitatively determining the concentration of one or more analyte in a fluid test sample which comprises the steps of: a) providing a test strip comprising a matrix through which the fluid test sample can flow by capillarity said strip having a first region wherein the first region contains mobile specific binding partner for the analyte which binding partner bears a detectable label and can react with the analyte to form an analyte/labeled binding partner complex, at least one second region which contains an immobilized analyte or analog thereof and at least one third region which contains means for immobilizing the complex formed between the analyte and labeled binding partner; b) developing the strip by applying the fluid test sample suspected of containing the analyte thereto to allow the same to contact the mobile specific binding partner whereby analyte present in the fluid test sample binds to the labeled specific binding partner to form the complex leaving excess, unreacted labeled binding partner free to further react whereby the fluid test sample carries the analyte/labeled binding partner complex and unreacted labeled binding partner along the strip by capillarity to the second region containing the immobilized analyte or analog thereof in which region unreacted labeled binding partner is bound to the immobilized analyte in inverse relationship to the concentration of the analyte in the fluid test sample and the analyte/labeled binding partner complex is carried by capillarity to the third region where it is captured by the immobilization means; c) reading the second zone of the developed strip on an instrument having a detector capable of measuring the signal from the detectable label to determine the concentration of the labeled binding partner in the second zone and reading the third zone of the developed strip in a similar manner to determine the signal from the labeled binding partner in the third zone of the strip; d) determining the ratio of the signal from the labeled binding partner immobilized in the second region to the signal from the labeled binding partner in the third region; and e) determining the concentration of the analyte in the fluid test sample by comparing the ratio of the signals measured in step c with the measurements of the ratios of the signals measured in the same manner for fluid samples containing known concentrations of the analyte.
Claim 13
Independent Claim
391 words
A method for quantitatively determining the concentration of one or more analyte in a fluid test sample which comprises the steps of: a) providing a test strip comprising a matrix through which the fluid test sample can flow by capillarity said strip having a first region wherein the first region contains mobile specific binding partner for the analyte which binding partner bears a detectable label and can react with the analyte to form an analyte/labeled binding partner complex, at least one second region which contains an immobilized analyte or analog thereof and at least one third region which contains means for immobilizing the complex formed between the analyte and labeled binding partner; b) developing the strip by applying the fluid test sample suspected of containing the analyte thereto to allow the same to contact the mobile specific binding partner whereby analyte present in the fluid test sample binds to the labeled specific binding partner to form the complex leaving excess, unreacted labeled binding partner free to further react whereby the fluid test sample carries the analyte/labeled binding partner complex and unreacted labeled binding partner along the strip by capillarity to the second region containing the immobilized analyte or analog thereof in which region unreacted labeled binding partner is bound to the immobilized analyte in inverse relationship to the concentration of the analyte in the fluid test sample and the analyte/labeled binding partner complex is carried by capillarity to the third region where it is captured by the immobilization means; c) reading the second zone of the developed strip on an instrument having a detector capable of measuring the signal from the detectable label to determine the concentration of the labeled binding partner in the second zone and reading the third zone of the developed strip in a similar manner to determine the signal from the labeled binding partner in the third zone of the strip; d) determining the ratio of the signal from the labeled binding partner immobilized in the second region to the signal from the labeled binding partner in the third region; and e) determining the concentration of the analyte in the fluid test sample by comparing the ratio of the signals measured in step c with the measurements of the ratios of the signals measured in the same manner for fluid samples containing known concentrations of the analyte.
Claim 14
Dependent Claim
13 words
The method of claim 11 wherein the measuring instrument is a reflectance spectrometer.
Claim 15
Dependent Claim
24 words
The method of claim 11 wherein the matrix is comprised of a material which is capable of non-bibulous lateral flow or a bibulous material.
Claim 16
Dependent Claim
12 words
The method of claim 11 wherein the analyte is human serum albumin.
Claim 17
Dependent Claim
13 words
The method of claim 11 wherein the detectable label is a gold sol.
Claim 18
Dependent Claim
13 words
The method of claim 11 wherein the labeled binding partner is an antibody.
References Cited (Backward Citations)
US4168146A
Cited
US4313734A
Cited
US4376110A
Cited
US4446232A
Cited
US4868108A
Cited
US4772561A
Cited
US4855109A
Cited
GB2204398A
Cited
US4943522A
Cited
US5120643A
Cited
US4833088A
Cited
US4859612A
Cited
US5110550A
Cited
US5141850A
Cited
US5308775A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1999-10-29 | 2000-04-29 | 2000-10-29 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2003-10-29 | 2004-04-29 | 2004-10-29 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2007-10-29 | 2008-04-29 | 2008-10-29 | $7700.00 | Window Closed / Lapsed |